IDEXX Laboratories Debt to Equity Ratio 2010-2024 | IDXX

Current and historical debt to equity ratio values for IDEXX Laboratories (IDXX) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. IDEXX Laboratories debt/equity for the three months ending September 30, 2024 was 0.32.
IDEXX Laboratories Debt/Equity Ratio Historical Data
Date Long Term Debt Shareholder's Equity Debt to Equity Ratio
2024-09-30 $1.73B $1.62B 1.07
2024-06-30 $1.84B $1.58B 1.16
2024-03-31 $1.79B $1.57B 1.14
2023-12-31 $1.78B $1.49B 1.20
2023-09-30 $1.79B $1.30B 1.38
2023-06-30 $1.78B $1.09B 1.62
2023-03-31 $1.97B $0.84B 2.34
2022-12-31 $2.14B $0.61B 3.51
2022-09-30 $2.16B $0.48B 4.55
2022-06-30 $2.15B $0.46B 4.71
2022-03-31 $1.95B $0.64B 3.05
2021-12-31 $1.75B $0.69B 2.53
2021-09-30 $1.63B $0.76B 2.16
2021-06-30 $1.66B $0.75B 2.22
2021-03-31 $1.62B $0.70B 2.31
2020-12-31 $1.66B $0.63B 2.63
2020-09-30 $1.61B $0.44B 3.64
2020-06-30 $1.69B $0.27B 6.17
2020-03-31 $1.78B $0.11B 16.46
2019-12-31 $1.66B $0.18B 9.31
2019-09-30 $1.55B $0.20B 7.64
2019-06-30 $1.55B $0.17B 9.05
2019-03-31 $1.63B $0.05B 31.41
2018-12-31 $1.55B $-0.01B -167.51
2018-09-30 $1.55B $-0.00B -1134.18
2018-06-30 $1.56B $-0.04B -38.23
2018-03-31 $1.52B $-0.05B -31.00
2017-12-31 $1.77B $-0.05B -32.82
2017-09-30 $1.72B $-0.05B -35.50
2017-06-30 $1.72B $-0.09B -20.01
2017-03-31 $1.65B $-0.07B -22.27
2016-12-31 $1.64B $-0.11B -15.15
2016-09-30 $1.45B $0.06B 26.29
2016-06-30 $1.50B $-0.01B -176.25
2016-03-31 $1.55B $-0.07B -21.04
2015-12-31 $1.56B $-0.08B -18.56
2015-09-30 $1.52B $-0.04B -39.07
2015-06-30 $1.47B $0.01B 171.77
2015-03-31 $1.40B $0.03B 40.99
2014-12-31 $1.27B $0.12B 10.77
2014-09-30 $1.06B $0.23B 4.62
2014-06-30 $0.83B $0.45B 1.83
2014-03-31 $0.75B $0.51B 1.46
2013-12-31 $0.71B $0.52B 1.38
2013-09-30 $0.66B $0.54B 1.24
2013-06-30 $0.61B $0.55B 1.12
2013-03-31 $0.50B $0.63B 0.79
2012-12-31 $0.47B $0.64B 0.74
2012-09-30 $0.48B $0.62B 0.77
2012-06-30 $0.48B $0.59B 0.81
2012-03-31 $0.49B $0.57B 0.87
2011-12-31 $0.49B $0.54B 0.91
2011-09-30 $0.38B $0.59B 0.65
2011-06-30 $0.34B $0.61B 0.56
2011-03-31 $0.31B $0.60B 0.52
2010-12-31 $0.32B $0.57B 0.56
2010-09-30 $0.32B $0.55B 0.58
2010-06-30 $0.31B $0.52B 0.59
2010-03-31 $0.33B $0.50B 0.66
2009-12-31 $0.29B $0.52B 0.57
2009-09-30 $0.32B $0.50B 0.63
2009-06-30 $0.33B $0.47B 0.70
2009-03-31 $0.33B $0.45B 0.73
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $35.676B $3.661B
IDEXX Laboratories, Inc. is a developer, manufacturer and distributer of products and services primarily for the companion animal veterinary, livestock and poultry, water testing and dairy markets. The company also sells a series of portable electrolytes and blood gas analyzers for the human point-of-care medical diagnostics market.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $202.480B 24.70
Intuitive Surgical (ISRG) United States $196.045B 102.50
Alcon (ALC) Switzerland $42.794B 28.63
Edwards Lifesciences (EW) United States $42.188B 26.79
IQVIA Holdings (IQV) United States $36.777B 20.26
DexCom (DXCM) United States $30.357B 45.72
Waters (WAT) United States $22.803B 33.72
STERIS (STE) Ireland $21.310B 24.53
SONOVA HOLDING (SONVY) Switzerland $20.157B 0.00
Hologic (HOLX) United States $17.098B 18.47
Fresenius Medical Care AG KGaA (FMS) Germany $14.119B 14.49
Sysmex ADR (SSMXY) Japan $13.255B 0.00
Globus Medical (GMED) United States $11.345B 28.73
Penumbra (PEN) United States $9.105B 89.18
Masimo (MASI) United States $9.091B 43.99
Teleflex (TFX) United States $8.576B 13.68
Glaukos (GKOS) United States $7.735B 0.00
PROCEPT BioRobotics (PRCT) United States $4.949B 0.00
Integer Holdings (ITGR) United States $4.675B 26.50
Veracyte (VCYT) United States $3.420B 102.63
Inari Medical (NARI) United States $2.990B 0.00
LivaNova (LIVN) United Kingdom $2.699B 15.58
Nihon Kohden (NHNKY) Japan $2.361B 17.93
TransMedics (TMDX) United States $2.291B 72.62
Elekta AB (EKTAY) Sweden $2.165B 19.47
Tandem Diabetes Care (TNDM) United States $1.978B 0.00
Integra LifeSciences Holdings (IART) United States $1.860B 9.72
RxSight (RXST) United States $1.739B 0.00
Alphatec Holdings (ATEC) United States $1.365B 0.00
Artivion (AORT) United States $1.243B 82.39
Pulse Biosciences (PLSE) United States $1.215B 0.00
OPKO Health (OPK) United States $1.085B 0.00
AVANOS MEDICAL, INC (AVNS) United States $0.849B 14.43
Paragon 28 (FNA) United States $0.840B 0.00
ORTHOFIX MEDICAL INC (OFIX) United States $0.712B 0.00
IRadimed (IRMD) United States $0.687B 37.11
Mesa Laboratories (MLAB) United States $0.674B 15.88
AxoGen (AXGN) United States $0.656B 0.00
SiBone (SIBN) United States $0.567B 0.00
OrthoPediatrics (KIDS) United States $0.561B 0.00
Pacific Biosciences Of California (PACB) United States $0.556B 0.00
Semler Scientific (SMLR) United States $0.512B 30.12
Treace Medical Concepts (TMCI) United States $0.494B 0.00
Tactile Systems Technology (TCMD) United States $0.439B 23.75
Delcath Systems (DCTH) United States $0.380B 0.00
ClearPoint Neuro (CLPT) United States $0.372B 0.00
NeuroPace (NPCE) United States $0.337B 0.00
CVRx (CVRX) United States $0.327B 0.00
AngioDynamics (ANGO) United States $0.284B 0.00
Inogen (INGN) United States $0.226B 0.00
Alpha Tau Medical (DRTS) Israel $0.210B 0.00
Accuray (ARAY) United States $0.202B 0.00
Sight Sciences (SGHT) United States $0.196B 0.00
KORU Medical Systems (KRMD) United States $0.174B 0.00
Nevro (NVRO) United States $0.157B 0.00
Atossa Genetics (ATOS) United States $0.153B 0.00
Sensus Healthcare (SRTS) United States $0.145B 15.49
Spectral Diagnostics (EDTXF) Canada $0.105B 0.00
Vicarious Surgical (RBOT) United States $0.095B 0.00
WORK Medical Technology Group (WOK) China $0.092B 0.00
LENSAR (LNSR) United States $0.089B 0.00
EDAP TMS S.A (EDAP) France $0.081B 0.00
InspireMD (NSPR) Israel $0.080B 0.00
908 Devices (MASS) United States $0.080B 0.00
Monogram Orthopaedics (MGRM) United States $0.077B 0.00
Covalon Technologies (CVALF) Canada $0.073B 0.00
Hyperfine (HYPR) United States $0.071B 0.00
EnVVeno Medical (NVNO) United States $0.054B 0.00
Lucid Diagnostics (LUCD) United States $0.050B 0.00
Rapid Micro Biosystems (RPID) United States $0.045B 0.00
Envoy Medical (COCH) United States $0.045B 0.00
Accelerate Diagnostics (AXDX) United States $0.040B 0.00
Spectral AI (MDAI) United States $0.039B 0.00
Neuronetics (STIM) United States $0.039B 0.00
Adagio Medical Holdings (ADGM) United States $0.033B 0.00
Precision Optics (POCI) United States $0.032B 0.00
DarioHealth (DRIO) United States $0.026B 0.00
Biosig Technologies (BSGM) United States $0.024B 0.00
NexGel (NXGL) United States $0.024B 0.00
Microbot Medical (MBOT) United States $0.017B 0.00
Inspira Technologies OXY B.H.N (IINN) Israel $0.016B 0.00
Ekso Bionics Holdings (EKSO) United States $0.015B 0.00
Aspira Women's Health (AWH) United States $0.013B 0.00
Baird Medical Investment Holdings (BDMD) $0.012B 0.00
QT Imaging Holdings (QTI) United States $0.011B 0.00
PAVmed (PAVM) United States $0.011B 0.00
T2 Biosystems (TTOO) United States $0.011B 0.00
Tenon Medical (TNON) United States $0.007B 0.00
Nuwellis (NUWE) United States $0.006B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.005B 0.00
Check-Cap (CHEK) Israel $0.005B 0.00
Autonomix Medical (AMIX) United States $0.005B 0.00
ReShape Lifesciences (RSLS) United States $0.004B 0.00
ENDRA Life Sciences (NDRA) United States $0.003B 0.00
Nanovibronix (NAOV) United States $0.003B 0.00
Avinger (AVGR) United States $0.003B 0.00
Bluejay Diagnostics (BJDX) United States $0.002B 0.00
Helius Medical Technologies (HSDT) United States $0.002B 0.00
Venus Concept (VERO) Canada $0.002B 0.00
Longview Acquisition II (LGV) United States $0.000B 0.00
Spinal Elements Holdings (SPEL) United States $0.000B 0.00